S2Medical AB (publ) publishes annual report for 2021

S2Medicals annual report for 2021 has today been published on the Company’s website https://www.s2m.se/en/press-releases. Printed copies will be made available in conjunction with the annual general meeting on June 1st 2022. Shareholders wishing to receive a printed copy of the annual report are asked to order it by email sent to hello@s2m.se.

This disclosure contains information that S2Medical AB is obliged to make public pursuant to the Swedish Securities Markets Act (2007:528). The information was submitted for publication, through the agency of the contact person, on 26-04-2022 09:01 CET.

Contact Details
Petter Sivlér – CEO, S2Medical AB (publ)
Telephone: +46 (0)8-70 000 50
E-mail: petter.sivler@s2m.se

Certified Adviser
Vator Securities AB
Telephone +46 (0)8-580 065 99
Website: www.vatorsec.se 
E-mail: ca@vatorsec.se

About S2Medical 

S2Medical AB (publ) is a medical technology company that develops and sells innovative wound healing products for the entire wound healing process, with a focus on burns and chronic wounds. The company has developed eiratex®, a new cellulose-based material for healing severe burns and chronic wounds. The material heals wounds effectively and thereby reduces both suffering for patients and costs for health care.

Share's ticker: S2M

Share's ISIN-code: SE0011725084